MedPath

WHAT WORKS for parents with intellectual disabilities? Research on parenting support

Completed
Conditions
verstandelijke beperkingen
intellectual disabilities
Registration Number
NL-OMON34628
Lead Sponsor
Vrije Universiteit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

1. The mother has Intellectual Disabilities (ID, IQ 50-70) or Borderline Intellectual Functioning (BIF, IQ 70-85).
2. At least one of the children is between age 1.0 and 6.11 till (follow-up) measures are completed.
3. The parent(s) and the child(ren) have a stable housing situation.

Exclusion Criteria

1. All children have reached age 7 or will reach age 7 within 6 months.
2. The target child is placed out of the home.
3. The target child has classic autistic disorder.
4. There is an acute report at the Child Protection Board (CPB, in Dutch: Raad voor de Kinderbescherming) because the child*s safety is at issue.;Exclusion criteria 2 to 4 can occur or come to light during the course of the study. The study will in these cases be discontinued, and new participants will be recruited.;For families who are considered for participation in Study 2, one exclusion criterion is added:
5. The family is receiving video-home training already.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>In study 1 relations are investigated between the inclination to ask and accept<br /><br>professional parenting support as a dependent variable and working alliance<br /><br>with the professional caretaker, level of adaptive functioning and reading<br /><br>skills, former experience with service providers, perceived need for support<br /><br>and more objective indicators of need for support as explanatory variables. In<br /><br>study 2, the effects of the VIPP-intervention on sensitive responsiveness,<br /><br>positive discipline, parent-child interaction and parenting stress will be<br /><br>investigated. Explanatory variables from study 1 will be used as control<br /><br>variables in study 2. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>n.a.</p><br>
© Copyright 2025. All Rights Reserved by MedPath